Dr. Kimball Johnson, MD
Claim this profileiResearch Atlanta
Studies Alzheimer's Disease
Studies Dementia
22 reported clinical trials
21 drugs studied
Area of expertise
1Alzheimer's Disease
Stage II
Stage III
Stage IV
2Dementia
Affiliated Hospitals
Clinical Trials Kimball Johnson, MD is currently running
LY4006895
for Alzheimer's Disease
The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY4006895. Part A will administer a single-ascending dose in healthy participants or Part B will administer multiple-ascending doses in participants with early symptomatic Alzheimer's Disease (AD). Blood tests will be performed to check how much LY4006895 gets into the bloodstream and how long it takes the body to eliminate it. This is a 2-part study and will last approximately 29 weeks for Part A and 61 weeks for Part B, including a screening period for each part.
Recruiting0 awards Phase 11 criteria
Mevidalen
for Alzheimer's Disease
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Recruiting0 awards Phase 21 criteria
More about Kimball Johnson, MD
Clinical Trial Related5 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Kimball Johnson, MD has experience with
- Placebo
- Donanemab
- Serdexmethylphenidate (SDX) And Dexmethylphenidate (d-MPH)
- Buntanetap
- Tirzepatide
- CYB004
Breakdown of trials Kimball Johnson, MD has run
Alzheimer's Disease
Dementia
Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kimball Johnson, MD specialize in?
Kimball Johnson, MD focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved Stage II patients, or patients who are Stage III.
Is Kimball Johnson, MD currently recruiting for clinical trials?
Yes, Kimball Johnson, MD is currently recruiting for 5 clinical trials in Decatur Georgia. If you're interested in participating, you should apply.
Are there any treatments that Kimball Johnson, MD has studied deeply?
Yes, Kimball Johnson, MD has studied treatments such as Placebo, Donanemab, Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH).
What is the best way to schedule an appointment with Kimball Johnson, MD?
Apply for one of the trials that Kimball Johnson, MD is conducting.
What is the office address of Kimball Johnson, MD?
The office of Kimball Johnson, MD is located at: iResearch Atlanta, Decatur, Georgia 30030 United States. This is the address for their practice at the iResearch Atlanta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.